Is It Too Late to Buy Micron Technology Stock After Its 12-Month Gain of 700%?

Micron reported record fiscal Q2 revenue of $23.8 billion, up 196% year over year, and EPS of $12.07, up 756%, with management guiding Q3 revenue to $33.5 billion and EPS to $18.90. The article highlights surging demand for AI-related HBM memory, with 2026 supply already sold out and HBM4 now in production, but cautions that eventual capacity additions could normalize pricing and compress future earnings. Wall Street’s fiscal 2027 EPS estimate of $101.78 implies a forward P/E of 7.8, versus a trailing P/E of 37.4.

Analysis

Micron is no longer just a memory cyclical; it has become a bottleneck asset inside the AI stack. The second-order effect is that hyperscalers and GPU vendors are being forced to carry more inventory and commit longer-dated supply, which should keep near-term pricing unusually firm and support the entire HBM ecosystem — but it also tightens working capital and raises the probability of demand pull-forward followed by a digestion phase in 12-18 months.

The market is implicitly discounting that this is peak scarcity economics, not a permanent margin regime. That matters because the fastest earnings revisions are usually the most fragile once capacity additions catch up; the key variable is not whether HBM demand grows, but whether incremental bits can be supplied fast enough to prevent price dislocation. In that sense, the strongest upside is likely in the next few quarters, while the risk-reward deteriorates as 2027 supply chains normalize.

Relative winners include NVDA and AMD on performance-per-watt improvements, but they face a subtle risk: if HBM remains constrained, GPU roadmap adoption may bottleneck at the memory layer rather than compute. Conversely, if Micron executes flawlessly on HBM4 ramp, it can pressure smaller memory players and force share shifts, but it also accelerates the eventual commoditization cycle by inviting more capacity investment from the rest of the industry.

The contrarian view is that the valuation is not actually cheap on normalized earnings power; it is cheap only if scarcity persists longer than consensus expects. The right way to underwrite this is as a time-spread trade on the cycle: the next 2-4 quarters likely remain favorable, but the 12-24 month setup depends on whether supply additions are disciplined or race-to-the-bottom. The biggest mistake would be treating a peak-margin scarcity story like a durable secular compounder.

Key Decisions for Investors

• Long MU tactically for the next 2-3 quarters; use a size cap and plan to trim into strength as FY26 supply tightness remains the dominant driver. Risk/reward is favorable while pricing power is intact, but the thesis decays quickly once capacity catches up.
• Buy MU call spreads instead of outright equity to express upside into the next earnings cycle; target 3-6 month tenor to capture revision momentum while limiting downside if the market starts discounting normalization earlier than expected.
• Pair trade: long MU / short a basket of lower-quality memory or commodity semiconductor exposure. The relative edge is execution on HBM mix and margin capture, while the short leg helps isolate the scarcity premium from broad semiconductor beta.
• Stay long NVDA, but hedge with a small MU position rather than assuming GPU demand alone is enough; if memory remains constrained, the bottleneck shifts from compute to supply chain, which can cap near-term AI shipment upside.
• Set a 12-18 month calendar reminder to reassess the cycle: if HBM supply announcements from peers start accelerating, rotate out of MU before consensus EPS gets revised down from peak margin levels.